http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021060166-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ed8d7a6d42fa7a3ee0fcf6de6dae06c1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_104416861228b4eb939f111cf7428659 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e58b0a2a2787e908ca473d9b68636665 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1075 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-08 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-107 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26 |
| filingDate | 2020-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dfcdc6024833e7ec1d205f50acc74ae2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce62807471a608832347ca9295b8a721 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d68d79f5e2b01a49f649afdc692ad9bd |
| publicationDate | 2021-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2021060166-A1 |
| titleOfInvention | Method for the preparation of a 1,7-bis (4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione system in polysorbates for the formation of micelles in an aqueous medium aimed at the properties of the bioavailability of curcuminoids |
| abstract | The invention relates to the preparation of a mixture of 1,7-bis (4-hydroxy-3-methoxyphenyl)-1,6-heptadien-3,5-dione in polysorbates that allows the formation of micelles in water loaded with 1,7-bis (4-hydroxy-3-methoxyphenyl)-1,6-heptadien-3,5-dione. With the developed formulation it is proposed to avoid bioavailability problems of this molecule, allowing to better demonstrate its benefits directed to systemic therapeutic effects, for example, anti-inflammatory drugs, and to reduce the use of drugs that cause direct or indirect irritation to the gastrointestinal mucosa, kidney damage, Cushing syndrome and/or immunosuppression. |
| priorityDate | 2019-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 180.